Literature DB >> 26629199

Role of IL-1β, IL-6, IL-8 and IFN-γ in pathogenesis of central nervous system neuropsychiatric systemic lupus erythematous.

Ji-Bo Wang1, Hua Li1, Li-Li Wang1, Hong-Da Liang1, Lei Zhao1, Jing Dong1.   

Abstract

We discussed the role of IL-1β, IL-6, IL-8 and IFN-γ in the pathogenesis of central nervous system neuropsychiatric systemic lupus erythematous (CNS-NPSLE). Serum and cerebrospinal fluid samples were collected from CNS-NPSLE patients, non-CNS SLE patients, patients with intracranial infection and normal subjects. Levels of IL-1β, IL-6, IL-8 and IFN-γ in serum and cerebrospinal fluid were detected by ELISA, and the results were compared across the groups. All subjects received cerebral MRI. The risk threshold for each cytokine in CNS-NPSLE group was set as 2.5%. The positive rates of cytokines for different lesions in cerebral MRI findings in CNS-NPSLE group were compared. The correlations between cytokine levels and cerebral MRI findings were analyzed. All groups did not show significant differences in age and gender (F=1.34, P>0.05; x (2)=2.05, P>0.05); The IL-1β, IL-6, IL-8 and IFN-γ levels of serum and cerebrospinal fluid in CNS-NPSLE group were obviously higher than those of the normal control (serum Z14 =6.22, 6.04, 6.22, 5.70; cerebrospinal fluid Z14 =6.38, 7.10, 6.97, 6.34, P<0.0083); IL-1β, IL-6 and IL-8 levels of cerebrospinal fluid of CNS-NPSLE group were higher than those of the non-CNS SLE group (Z12 =2.73, Z12 =3.18, Z12 =3.86; P<0.0083); IL-1β, IL-6, IL-8 and IFN-γ levels of cerebrospinal fluid of CNS-NPSLE group were higher than those of the serum (Z=3.19, 6.30, 5.44, 3.19, P<0.05); IL-6>20.0679 pg/ml and IL-8>87.1811 pg/ml in the cerebrospinal fluid predicted a higher risk of CNS-NPSLE (x (2)=11.98, P<0.05; x (2)=4.65, P<0.05); The positive rates of IL-1β and IL-6 in the cerebrospinal fluid of CNS-NPSLE patients with demyelinating diseases were considerably higher than those of CNS-NPSLE patients with normal MRI findings (x (2)=10.89, P<0.005; x (2)=18.47, P<0.005). The positive rates of IL-6 and IFN-γ in the cerebrospinal fluid of CNS-NPSLE patients presenting with multiple ischemic foci were significantly higher than those with normal MRI findings (x (2)=5.56, P<0.005; x (2)=14.59, P<0.005). Some cytokines are involved in the pathogenesis of CNS-NPSLE and correlated with cerebral MRI findings in CNS-NPSLE.

Entities:  

Keywords:  Neuropsychiatric systemic lupus erythematous (NPSLE); central nervous system (CNS); cytokines; logistic regression analysis

Year:  2015        PMID: 26629199      PMCID: PMC4659087     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  16 in total

1.  Cerebrospinal fluid soluble interleukin-2 receptor in cerebral lupus.

Authors:  R Gilad; Y Lampl; Y Eshel; V Barak; I Sarova-Pinhas
Journal:  Br J Rheumatol       Date:  1997-02

Review 2.  Neuropsychiatric features of systemic lupus erythematosus.

Authors:  Andrea T Borchers; Christopher A Aoki; Stanley M Naguwa; Carl L Keen; Yehuda Shoenfeld; M Eric Gershwin
Journal:  Autoimmun Rev       Date:  2005-03-22       Impact factor: 9.754

Review 3.  Optimizing clinical monitoring of central nervous system involvement in SLE.

Authors:  G Castellino; M Govoni; S Giacuzzo; F Trotta
Journal:  Autoimmun Rev       Date:  2007-12-17       Impact factor: 9.754

Review 4.  The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes.

Authors: 
Journal:  Arthritis Rheum       Date:  1999-04

5.  Neuropsychiatric syndromes in systemic lupus erythematosus: a meta-analysis.

Authors:  Avraham Unterman; Johannes E S Nolte; Mona Boaz; Maya Abady; Yehuda Shoenfeld; Gisele Zandman-Goddard
Journal:  Semin Arthritis Rheum       Date:  2010-10-20       Impact factor: 5.532

6.  Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance.

Authors:  John G Hanly; Grace McCurdy; Lisa Fougere; Jo-Anne Douglas; Kara Thompson
Journal:  J Rheumatol       Date:  2004-11       Impact factor: 4.666

Review 7.  Pathogenesis of neuropsychiatric systemic lupus erythematosus and potential biomarkers.

Authors:  Petros Efthimiou; Michelle Blanco
Journal:  Mod Rheumatol       Date:  2009-07-18       Impact factor: 3.023

8.  Activation of the interferon-gamma signaling pathway in systemic lupus erythematosus peripheral blood mononuclear cells.

Authors:  Thomas Karonitsch; Eva Feierl; Carl Walter Steiner; Karolina Dalwigk; Adelheid Korb; Nikolaus Binder; Alfred Rapp; Günter Steiner; Clemens Scheinecker; Josef Smolen; Martin Aringer
Journal:  Arthritis Rheum       Date:  2009-05

9.  Potent induction of IFN-alpha and chemokines by autoantibodies in the cerebrospinal fluid of patients with neuropsychiatric lupus.

Authors:  Deanna M Santer; Taku Yoshio; Seiji Minota; Thomas Möller; Keith B Elkon
Journal:  J Immunol       Date:  2009-01-15       Impact factor: 5.422

10.  Evaluation of brain and cervical MRI abnormality rates in patients with systemic lupus erythematosus with or without neurological manifestations.

Authors:  Mohammad Hossein Harirchian; Hazhir Saberi; Seyed Reza Najafizadeh; Seyed Ali Hashemi
Journal:  Iran J Radiol       Date:  2011-11-25       Impact factor: 0.212

View more
  15 in total

Review 1.  Neuropsychiatric lupus: new mechanistic insights and future treatment directions.

Authors:  Noa Schwartz; Ariel D Stock; Chaim Putterman
Journal:  Nat Rev Rheumatol       Date:  2019-03       Impact factor: 20.543

2.  Cognitive impairment in rheumatoid arthritis: role of lymphocyte subsets, cytokines and neurotrophic factors.

Authors:  Laura E Petersen; Talita S A Baptista; Júlia K Molina; Julia G Motta; Aline do Prado; Deise M Piovesan; Tatiana de Nardi; Thiago W Viola; Érica L M Vieira; Antonio L Teixeira; Rodrigo Grassi-Oliveira; Moisés Evandro Bauer
Journal:  Clin Rheumatol       Date:  2018-01-25       Impact factor: 2.980

3.  Plasma cytokine changes and its clinical significance in intracranial infection secondary to traumatic brain injury.

Authors:  Nannan Zhang; Zhibo Zhang; Hongxiao Wang; Dan Liu; Yingying Deng
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

4.  Negative regulation of IL-8 in human astrocytes depends on β-catenin while positive regulation is mediated by TCFs/LEF/ATF2 interaction.

Authors:  KaReisha F Robinson; Srinivas D Narasipura; Jennillee Wallace; Ethan M Ritz; Lena Al-Harthi
Journal:  Cytokine       Date:  2020-08-17       Impact factor: 3.861

Review 5.  Interleukin-6 Signaling Pathway and Its Role in Kidney Disease: An Update.

Authors:  Hua Su; Chun-Tao Lei; Chun Zhang
Journal:  Front Immunol       Date:  2017-04-21       Impact factor: 7.561

6.  IL-1β and IL-6 Are Highly Expressed in RF+IgE+ Systemic Lupus Erythematous Subtype.

Authors:  Yongkang Wu; Bei Cai; Junlong Zhang; Beilei Shen; Zhuochun Huang; Chunyu Tan; Carla C Baan; Lanlan Wang
Journal:  J Immunol Res       Date:  2017-02-12       Impact factor: 4.818

Review 7.  Neuropsychiatric Systemic Lupus Erythematosus Involvement: Towards a Tailored Approach to Our Patients?

Authors:  Raquel Faria; João Gonçalves; Rita Dias
Journal:  Rambam Maimonides Med J       Date:  2017-01-30

8.  Distinct alterations of CD68+CD163+ M2-like macrophages and myeloid-derived suppressor cells in newly diagnosed primary immune thrombocytopenia with or without CR after high-dose dexamethasone treatment.

Authors:  Xia Shao; Boting Wu; Luya Cheng; Feng Li; Yanxia Zhan; Chanjuan Liu; Lili Ji; Zhihui Min; Yang Ke; Lihua Sun; Hao Chen; Yunfeng Cheng
Journal:  J Transl Med       Date:  2018-03-02       Impact factor: 5.531

Review 9.  The role of inflammation in the development of epilepsy.

Authors:  Amna Rana; Alberto E Musto
Journal:  J Neuroinflammation       Date:  2018-05-15       Impact factor: 8.322

10.  Expression and clinical significance of the NEK7-NLRP3 inflammasome signaling pathway in patients with systemic lupus erythematosus.

Authors:  Zhen-Zhen Ma; Hong-Sheng Sun; Ji-Cai Lv; Lei Guo; Qing-Rui Yang
Journal:  J Inflamm (Lond)       Date:  2018-09-03       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.